FIELD: medicine, experimental pharmacology. SUBSTANCE: it is used an application of an aqueous isothiorbamine solution for animals in artificial instrumental environment: problematic chamber, lifted cross-shaped labyrinth and open field. The method enables to increase the number of preparations to decrease anxiety level in laboratory animals. EFFECT: higher efficiency. 3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TESTING PREPARATIONS WITH POTENTIAL PSYCOTROPIC OR ACT-PROTECTIVE ACTION | 2015 |
|
RU2601376C1 |
ANTIANXIETY DRUGS AND PHARMACEUTICAL COMPOSITIONS WITH ANXIOLYTIC EFFECTS | 2014 |
|
RU2580311C1 |
PHENYLHYDRAZIDE (4-PHENYL-2-PYRROLIDON-1-YL)-ACETIC ACID, HAVING NOOTROPIC, ANTIDEPRESSANT AND ANXIOLYTIC ACTIVITY | 2010 |
|
RU2440981C1 |
QUINAZOLINE DERIVATIVES, POSSESSING ANTIDEPRESSANT, ANXIOLYTIC AND NOOTROPIC ACTIVITY | 2012 |
|
RU2507199C1 |
ANTIDEPRESSANT FOR CORRECTION OF SIDE EFFECTS FROM NEUROLEPTICS | 2019 |
|
RU2746012C2 |
9-[2-(4-ISOPROPYLPHENOXY)ETHYL]ADENINE POSSESSING ANTIDEPRESSANT AND STRESS-RELIEVING ACTION | 2013 |
|
RU2529817C1 |
METHOD FOR RECORDING AND ANALYZING ANIMAL SEARCH ACTIVITY IN PROBLEM CHAMBER | 2000 |
|
RU2204942C2 |
MEDICATION POSSESSING ANTIDEPRESSIVE, ANXIOLYTIC AND NOOTROPIC ACTION | 2010 |
|
RU2437659C1 |
PEPTIDE POSSESSING NEUROTROPIC PROPERTIES | 2011 |
|
RU2443712C1 |
PEPTIDE POSSESSING NEUROTROPIC PROPERTIES | 2011 |
|
RU2443711C1 |
Authors
Dates
2003-01-20—Published
2001-02-08—Filed